Figure 1 | Scientific Reports

Figure 1

From: Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19

Figure 1

Kaplan–Meier curves of SARS CoV-2 infection clearance by SOF/VEL treatment (lines A,B) and spontaneously (line C; untreated control patients). Line (A): recovery time from infection starting from the first day of treatment with SOF/VEL. Lines (B,C) recovery time from infection starting from the first positive nasopharyngeal swab. Log-rang test: χ2 = 307.02, p < 0.0001.

Back to article page